-
Federal
Hepatic adverse events during highly active antiretroviral therapy containing nevirapine: a case report
U.S. Department of Health & Human Services —
Background Hepatotoxicity is one of the most serious complications of highly active antiretroviral therapy (HAART). The aim of this report is to analyse an HIV... -
Federal
Continuing HIV therapy in the ICU
U.S. Department of Health & Human Services —
The risks and benefits of stopping antiretroviral therapy in patients admitted to the ICU are largely unmeasured. In many cases therapy has to be stopped, as... -
Federal
Fast relapse and high drop out rate of 48 weeks daily interferon monotherapy in HIV-infected patients with chronic hepatitis C
U.S. Department of Health & Human Services —
Background The standard of care for HCV Hepatitis is the combination of interferon (IFN) plus Ribavirin. In HIV patients the use of this combination therapy may...